Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.62 | N/A |
| PEG Ratio (TTM) | -31.13 | N/A |
| P/S Ratio (TTM) | 1.71 | N/A |
| P/B Ratio (TTM) | 1.06 | N/A |
| P/FCF Ratio (TTM) | 11.77 | N/A |
| Price to 5YR AVG Earnings Ratio | 8.00 | N/A |
| Price to 5YR AVG FCF Ratio | 8.97 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.64% | N/A |
| ROE (TTM) | 9.55% | N/A |
| Net Profit Margin (TTM) | 13.05% | N/A |
| ROIC 5YR AVG | 7.78% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 0.29% | 3.90% | -5.35% |
| Revenue | 12.81% | 5.72% | -0.08% |
| Net Income | 0.23% | 4.04% | -5.49% |
| Cash Flow | 28.10% | 38.22% | 10.94% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 2.63 | N/A |
| Interest Coverage (TTM) | 0.33 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.34 | N/A |
| LTL to 5YR AVG FCF | 10.40 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.28% | N/A |